Skip to content

DrugPatentWatch - Transform Data into Market Domination

Business Intelligence on Biologic and Small Molecule Drugs

Blog Home
DrugPatentWatch Home
Pricing
About
Contact

DrugPatentWatch - Transform Data into Market Domination

Business Intelligence on Biologic and Small Molecule Drugs

Blog Home
DrugPatentWatch Home
Pricing
About
Contact

Drug Patent Expirations for the Week of November 30, 2025

By / December 4, 2025

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

NESINA (alogliptin benzoate)

Takeda pharms usa Patent: 8,173,663 Expiration: Dec 2, 2025

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at

Related Posts:

The New Biologic Gold Rush: Patent Strategy in the…
The End of Exclusivity: Navigating the Drug Patent…
Valuation of Pharmaceutical Companies: A…
Setting the Correct Medicine Launch Prices: A…
Top 6 issues facing the biotechnology industry
When Do Drug Patents Expire: Understanding the…
The Invisible Backbone: A Strategic Report on…
Mastering the New Rules of Small Molecule-Biologic…
What Happens When a Drug Patent Expires?…
The Billion-Dollar Equation: Mastering Patent Term…
How AI Is Irrevocably Altering the DNA of Drug Development
How Long Does a Patent Last for Drugs? A…
First Generic Launch has Significant First-Mover…
Drug APIs Start Here: How to Nail Your KSM Strategy
Licensing Agreements in the Pharmaceutical Sector
Drugs and Devices: Comparison of European and U.S.…
Review of Drugs Approved via the 505(b)(2) Pathway:…
The Patent Cliff's Shadow: Impact on Branded…
The Patent Playbook for Pharma: Protect Your Drug.…
The Missing Ingredient: Why Patent Data Is the Key…
AI-Powered Portfolio Management in Pharmaceuticals
8 Applications of Machine Learning in The…
Effective Drug Patent Prosecution Strategies:…
Viagra’s Generic Cliff: Why It Wasn’t a Free-for-All

The Uncoupling of Device and Drug: A Strategic Post-Mortem of Teva v. Amneal and the New Era of Orange Book Rigor

Navigating the Maze: A Guide to European SPCs for Generic Drug Planners

Related Posts

Drug Patent Expirations for the Week of August 10, 2025

Patent Expiration / By

Drug Patent Expirations for the Week of August 17, 2025

Patent Expiration / By

Make Better Decisions

See Plans & Pricing

Recent Posts

The Generic’s Gauntlet: A Strategic Playbook for ANDA Filing and Market Domination
From Chaos to Calculation: A Comprehensive Report on Algorithmic Drug Portfolio Optimization
The AI Revolution in Drug Repurposing: A Comprehensive Pipeline Analysis from Target Identification to Clinical and Commercial Validation
How Financial Analysts Use Drug Patent Expiry Data to Predict Pharma Stock Movements
The Myth of the “Clean” Patent Expiry in Pharmaceuticals: Strategic Analysis of Loss of Exclusivity, Patent Thickets, and Market Entry Dynamics

Popular Posts

The Pharmaceutical Gambit: An Analysis of Why India Lags China and a Roadmap to Competitive Parity
Valuation of Pharmaceutical Companies: A Comprehensive Analysis of Key Considerations
A Definitive Guide to Valuing Pharmaceutical and Biotech Companies
The AI Revolution in Drug Repurposing: A Comprehensive Pipeline Analysis from Target Identification to Clinical and Commercial Validation
Top 6 issues facing the biotechnology industry
PBMs, Formularies, and Rebates: What Investors Should Know
The New Pharma Playbook: A 2025-2030 Guide to Market Domination in a Data-Driven World
How Long Does a Patent Last for Drugs? A Comprehensive Guide to Pharmaceutical Patent Duration
Comprehensive Guide to Pharmaceutical Portfolio Management: Essential Reading Resources
The Rise of Telehealth Companies Like Ro and Hims & Hers: How Direct-to-Consumer Telehealth Redefined the Pharmaceutical Value Chain

Copyright © 2025 DrugPatentWatch - Transform Data into Market Domination

DrugPatentWatch - Transform Data into Market Domination

Subscribe to Free Updates

3,000+ other biopharma execs get our Drug Patent Expiration Alerts. You should too!

Get fresh news and insights, drug patent expirations & more…

EmailEnter your email address

Thanks, I’m not interested

Last Updated on December 4, 2025 by